Literature DB >> 17487255

Respiratory motor activity: influence of neuromodulators and implications for sleep disordered breathing.

Richard L Horner1.   

Abstract

Sleep, especially rapid-eye-movement sleep, causes fundamental modifications of respiratory muscle activity and control mechanisms, modifications that can predispose individuals to sleep-related breathing disorders. One of the most common of these disorders is obstructive sleep apnea (OSA) that affects approximately 4% of adults. OSA is caused by repeated episodes of pharyngeal airway obstruction that can occur hundreds of times per night, leading to recurrent asphyxia, arousals from sleep, daytime sleepiness, and adverse cardiovascular and cerebrovascular consequences. OSA is caused by the effects of sleep on pharyngeal muscle tone in individuals with already narrow upper airways. Moreover, since OSA occurs only in sleep, this disorder by definition is a state-dependent process ultimately caused by the influence of sleep neural mechanisms on the activity of pharyngeal motoneurons. This review synthesizes recent findings relating to control of pharyngeal muscle activity across sleep-wake states, with special emphasis on the influence of neuromodulators acting at the hypoglossal motor nucleus that inervates the genioglossus muscle of the tongue. The results of such basic physiological studies may be relevant to identifying and developing new pharmacological strategies to augment pharyngeal muscle activity in sleep, especially rapid-eye-movement sleep, as potential treatments for OSA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17487255     DOI: 10.1139/y06-089

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  25 in total

1.  GAD67-GFP+ neurons in the Nucleus of Roller: a possible source of inhibitory input to hypoglossal motoneurons. I. Morphology and firing properties.

Authors:  J F M van Brederode; Y Yanagawa; A J Berger
Journal:  J Neurophysiol       Date:  2010-11-03       Impact factor: 2.714

2.  Gasping generation in developing Swiss-Webster mice in vitro and in vivo.

Authors:  Fernando Peña; Roberto Meza-Andrade; Victor Páez-Zayas; María-Carmen González-Marín
Journal:  Neurochem Res       Date:  2008-02-14       Impact factor: 3.996

Review 3.  Pathophysiology of adult obstructive sleep apnea.

Authors:  Danny J Eckert; Atul Malhotra
Journal:  Proc Am Thorac Soc       Date:  2008-02-15

4.  Are all motoneurons created equal in the eyes of REM sleep and the mechanisms of muscle atonia?

Authors:  Gregory D Funk
Journal:  Sleep       Date:  2008-11       Impact factor: 5.849

5.  Hypoglossal premotor neurons of the intermediate medullary reticular region express cholinergic markers.

Authors:  Denys V Volgin; Irma Rukhadze; Leszek Kubin
Journal:  J Appl Physiol (1985)       Date:  2008-09-04

6.  Quantitative analysis of the excitability of hypoglossal motoneurons during natural sleep in the rat.

Authors:  Victor B Fenik; Simon J Fung; Vincent Lim; Michael H Chase
Journal:  J Neurosci Methods       Date:  2012-09-24       Impact factor: 2.390

7.  Determinants of frequency long-term facilitation following acute intermittent hypoxia in vagotomized rats.

Authors:  Tracy L Baker-Herman; Gordon S Mitchell
Journal:  Respir Physiol Neurobiol       Date:  2008-03-18       Impact factor: 1.931

8.  Two-year-old with post-surgical hypoglossal nerve injury and obstructive sleep apnea.

Authors:  Lourdes M Delrosso; Romy Hoque; Eduardo Gonzalez-Toledo
Journal:  J Clin Sleep Med       Date:  2014-01-15       Impact factor: 4.062

9.  Postnatal changes in the expression of serotonin 2A receptors in various brain stem nuclei of the rat.

Authors:  Qiuli Liu; Margaret T T Wong-Riley
Journal:  J Appl Physiol (1985)       Date:  2008-04-17

10.  Noradrenaline triggers muscle tone by amplifying glutamate-driven excitation of somatic motoneurones in anaesthetized rats.

Authors:  Peter B Schwarz; Nicole Yee; Saba Mir; John H Peever
Journal:  J Physiol       Date:  2008-10-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.